These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 12379711)
1. Candida albicans killing by RAW 264.7 mouse macrophage cells: effects of Candida genotype, infection ratios, and gamma interferon treatment. Marcil A; Harcus D; Thomas DY; Whiteway M Infect Immun; 2002 Nov; 70(11):6319-29. PubMed ID: 12379711 [TBL] [Abstract][Full Text] [Related]
2. The pathogen Candida albicans hijacks pyroptosis for escape from macrophages. Uwamahoro N; Verma-Gaur J; Shen HH; Qu Y; Lewis R; Lu J; Bambery K; Masters SL; Vince JE; Naderer T; Traven A mBio; 2014 Mar; 5(2):e00003-14. PubMed ID: 24667705 [TBL] [Abstract][Full Text] [Related]
3. Candida albicans morphogenesis is not required for macrophage interleukin 1β production. Wellington M; Koselny K; Krysan DJ mBio; 2012 Dec; 4(1):e00433-12. PubMed ID: 23269828 [TBL] [Abstract][Full Text] [Related]
4. Contribution of Candida albicans cell wall components to recognition by and escape from murine macrophages. McKenzie CG; Koser U; Lewis LE; Bain JM; Mora-Montes HM; Barker RN; Gow NA; Erwig LP Infect Immun; 2010 Apr; 78(4):1650-8. PubMed ID: 20123707 [TBL] [Abstract][Full Text] [Related]
5. Stage specific assessment of Candida albicans phagocytosis by macrophages identifies cell wall composition and morphogenesis as key determinants. Lewis LE; Bain JM; Lowes C; Gillespie C; Rudkin FM; Gow NA; Erwig LP PLoS Pathog; 2012; 8(3):e1002578. PubMed ID: 22438806 [TBL] [Abstract][Full Text] [Related]
6. Suppression of type 2 NO-synthase activity in macrophages by Candida albicans. Schröppel K; Kryk M; Herrmann M; Leberer E; Röllinghoff M; Bogdan C Int J Med Microbiol; 2001 Mar; 290(8):659-68. PubMed ID: 11310444 [TBL] [Abstract][Full Text] [Related]
7. Augmentation of GG2EE macrophage cell line-mediated anti-Candida activity by gamma interferon, tumor necrosis factor, and interleukin-1. Blasi E; Farinelli S; Varesio L; Bistoni F Infect Immun; 1990 Apr; 58(4):1073-7. PubMed ID: 2108087 [TBL] [Abstract][Full Text] [Related]
8. Role of trehalose in resistance to macrophage killing: study with a tps1/tps1 trehalose-deficient mutant of Candida albicans. Martínez-Esparza M; Aguinaga A; González-Párraga P; García-Peñarrubia P; Jouault T; Argüelles JC Clin Microbiol Infect; 2007 Apr; 13(4):384-94. PubMed ID: 17359322 [TBL] [Abstract][Full Text] [Related]
9. Altered dynamics of Candida albicans phagocytosis by macrophages and PMNs when both phagocyte subsets are present. Rudkin FM; Bain JM; Walls C; Lewis LE; Gow NA; Erwig LP mBio; 2013 Oct; 4(6):e00810-13. PubMed ID: 24169578 [TBL] [Abstract][Full Text] [Related]
10. Macrophage-dependent candidacidal mechanisms in the murine system. Comparison of murine Kupffer cell and peritoneal macrophage candidacidal mechanisms. Redmond HP; Shou J; Gallagher HJ; Kelly CJ; Daly JM J Immunol; 1993 Apr; 150(8 Pt 1):3427-33. PubMed ID: 8385685 [TBL] [Abstract][Full Text] [Related]
11. Relevance of Macrophage Extracellular Traps in Loureiro A; Pais C; Sampaio P Front Immunol; 2019; 10():2767. PubMed ID: 31866996 [No Abstract] [Full Text] [Related]
12. Candidacidal mechanisms of peritoneal macrophages activated with lymphokines or gamma-interferon. Brummer E; Stevens DA J Med Microbiol; 1989 Mar; 28(3):173-81. PubMed ID: 2494342 [TBL] [Abstract][Full Text] [Related]
13. Augmentation of human macrophage candidacidal capacity by recombinant human myeloperoxidase and granulocyte-macrophage colony-stimulating factor. Maródi L; Tournay C; Káposzta R; Johnston RB; Moguilevsky N Infect Immun; 1998 Jun; 66(6):2750-4. PubMed ID: 9596743 [TBL] [Abstract][Full Text] [Related]
14. Modulation of anti-Candida activity of human alveolar macrophages by interferon-gamma or interleukin-1-alpha. Vecchiarelli A; Todisco T; Puliti M; Dottorini M; Bistoni F Am J Respir Cell Mol Biol; 1989 Jul; 1(1):49-55. PubMed ID: 2516451 [TBL] [Abstract][Full Text] [Related]
16. Macrophage microbicidal activity. Correlation between phagocytosis-associated oxidative metabolism and the killing of Candida by macrophages. Sasada M; Johnston RB J Exp Med; 1980 Jul; 152(1):85-98. PubMed ID: 7400757 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. Maródi L; Schreiber S; Anderson DC; MacDermott RP; Korchak HM; Johnston RB J Clin Invest; 1993 Jun; 91(6):2596-601. PubMed ID: 8390485 [TBL] [Abstract][Full Text] [Related]
18. Murine defense mechanism against Candida albicans infection. II. Opsonization, phagocytosis, and intracellular killing of C. albicans. Kagaya K; Fukazawa Y Microbiol Immunol; 1981; 25(8):807-18. PubMed ID: 7026987 [TBL] [Abstract][Full Text] [Related]
19. Candida albicans induces pro-inflammatory and anti-apoptotic signals in macrophages as revealed by quantitative proteomics and phosphoproteomics. Reales-Calderón JA; Sylvester M; Strijbis K; Jensen ON; Nombela C; Molero G; Gil C J Proteomics; 2013 Oct; 91():106-35. PubMed ID: 23832136 [TBL] [Abstract][Full Text] [Related]
20. Human dendritic cells are less potent at killing Candida albicans than both monocytes and macrophages. Netea MG; Gijzen K; Coolen N; Verschueren I; Figdor C; Van der Meer JW; Torensma R; Kullberg BJ Microbes Infect; 2004 Sep; 6(11):985-9. PubMed ID: 15345229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]